Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
In total, 521 nonrespiratory specimens (91 urine, 30 gastric aspirate, 245 tissue, 113 pleural fluid, 19 cerebrospinal fluid [CSF], and 23 stool specimens) submitted to the German National Reference Laboratory for Mycobacteria (NRL) from May 2009 to August 2010 were comparatively investigated with the new molecular-based GeneXpert MTB/RIF (Xpert) assay system and conventional liquid and solid culture methods. Twenty (3.8%) of the 521 specimens gave no interpretable result. Whereas the sensitivity of the Xpert assay with tissue specimens was 69.0% (20 out of 29 culture-positive cases detected), 100% sensitivity was found with the urine and stool specimens. The combined sensitivity and specificity of the Xpert assay were calculated to be 77.3% and 98.2%, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In a study from Germany, 6 of 10 tuberculous lymphadenitis cases confirmed by culture were detected by the newer GeneXpert test; 3 cases with positive results had negative culture results, but subsequent investigation suggested that these were true cases [36].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [36]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Previous studies reported 98–100% agreement in detection of rifampicin resistance strains using the Xpert test and phenotypic drug susceptibility test [13,14,18,26].”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [14]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The various clinical presentations of EPTB are non-specific, and the disease is often paucibacillary leading to low sensitivities of routine diagnostic methods such as; acid-fast bacilli (AFB) microscopy [1–3] and culture [1, 4, 5].”
From MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar (2018) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In that study, the combined sensitivity and specificity of 77.3% and 98.2% were reported, respectively.”
From Xpert MTB/RIF for Rapid Diagnosis of Tuberculous Lymphadenitis from Fine-Needle-Aspiration Biopsy Specimens (2011) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Xpert® MTB/RIF (Cepheid, Sunnyvale, USA) is an automated, cartridge-based NAAT for the detection of M. tuberculosis complex and rifampicin drug-resistance from sputum and other specimens, with a turnaround time of less than two hours [19, 20].”
From Evaluation of Xpert® MTB/RIF and Ustar EasyNAT™ TB IAD for diagnosis of tuberculous lymphadenitis of children in Tanzania: a prospective descriptive study (2016) · cites this paper as [20]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 3×
“Molecular techniques have substantially changed the field of tuberculosis diagnosis and have been proven to yield rapid results while being highly sensitive (2).”
BackgroundInfluentialSelf-citationHelb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914 · cited 1×
“The Xpert assay was performed as recently described (11).”
MethodSelf-citationGlobal epidemiology of tuberculosis
Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68384-0 · Cited by 716
Hillemann, D., Rüsch-Gerdes, S., & Richter, E. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00521-07 · Cited by 345 · cited 1×
“Furthermore, sequencing showed an rpoB mutation in codon 533, resulting in a lysine-to-proline exchange, whose association with RMP resistance is debated (12, 15, 19).”
BackgroundSelf-citationTelenti, A., Honoré, N., Bernasconi, C., March, J., Ortega, A., Heym, B., Takiff, H. E., & Cole, S. T. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.719-723.1997 · Cited by 320 · cited 1×
“In all discordant cases, the 81-bp rpoB hot-spot region of culture isolates was analyzed by PCR and DNA sequencing with primers TR8 and TR9 to identify the presence or absence of rpoB core mutations (20).”
MethodLing, D. I., Flores, L. L., Riley, L. W., & Pai, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001536 · Cited by 222
El-Hajj, H. H., Marras, S. A. E., Tyagi, S., Kramer, F. R., & Alland, D. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.11.4131-4137.2001 · Cited by 180 · cited 1×
“To determine rifampin (RMP) resistance, the rifampin resistance-determining region of the rpoB gene is probed with molecular beacons (7).”
BackgroundRifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis
Taniguchi, H., Aramaki, H., Nikaido, Y., Mizuguchi, Y., Nakamura, M., Koga, T., & Yoshida, S.-I. (1996) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1996.tb08515.x · Cited by 154 · cited 4×
“These comprised 91 urine, 30 gastric aspirate, 245 tissue, 113 pleural fluid, 19 cerebrospinal fluid (CSF), and 23 stool specimens.”
BackgroundInfluentialRichter, E., Rüsch–Gerdes, S., & Hillemann, D. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1769-1775.2006 · Cited by 146 · cited 1×
“For the identification of MTBC organisms and the differentiation of MTBC and NTM from positive cultures, two commercially available DNA strip assays were used, the GenoType MTBC and CM/AS assays (Hain Lifescience GmbH, Nehren, Germany) (17, 18).”
MethodSelf-citationTechnology for Automated, Rapid, and Quantitative PCR or Reverse Transcription-PCR Clinical Testing
Raja, S., Ching, J., Xi, L., Hughes, S. J., Chang, R., Wong, W., McMillan, W., Gooding, W. E., McCarty, K. S., Chestney, M. L., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046474 · Cited by 136 · cited 1×
“The test runs on the GeneXpert platform (Cepheid, Sunnyvale, CA) using a disposable plastic cartridge with all required reagents (16).”
Method
Cited by
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Schiller, I., Horne, D. J., Pai, M., Boehme, C. C., & Dendukuri, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub3 · Cited by 1,102
Self-citationDenkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00007814 · Cited by 527
Self-citationLawn, S. D., & Nicol, M. P. (2011) · Future Microbiology · doi:10.2217/fmb.11.84 · Cited by 486
“assessed the utility of Xpert for TB diagnosis in nonrespiratory samples, including pleural fluid, gastric fluid, tissue, cerebrospinal fluid, urine and stool [25,31,32].”
BackgroundResultLawn, S. D., Mwaba, P., Bates, M., Piatek, A., Alexander, H., Marais, B. J., Cuevas, L. E., McHugh, T. D., Zijenah, L., Kapata, N., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70008-2 · Cited by 458
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Tortoli, E., Russo, C., Piersimoni, C., Mazzola, E., Dal Monte, P., Pascarella, M., Borroni, E., Mondo, A., Piana, F., Scarparo, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00176311 · Cited by 322
“The first study [11], similar to ours for the epidemiological background, omitted in the evaluation the clinical diagnosis, while the other [12] was carried out in a high prevalence TB country.”
Result
Metadata
- Authors
- Hillemann, D., Rüsch-Gerdes, S., Boehme, C., & Richter, E.
- Affiliations
- Research Center Borstel - Leibniz Lung Center (DE)
- Nationales Referenzzentrum für Mykobakterien, Forschungszentrum Borstel, Borstel, Germany
- FIND (CH)
- Corresponding author
- Hillemann, Doris
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2011-04
- Volume
- 49
- Issue
- 4
- Pages
- 1202-1205
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC3122824
- OpenAlex
- W2108234063
- Semantic Scholar
- 8a1ade3d18ad0c7efce7c5a71ea3d35d69eb764a
- Cited by
- 413
- References
- 18
- Citations by year
- 2026: 10 · 2025: 3 · 2024: 15 · 2023: 20 · 2022: 31 · 2021: 20 · 2020: 26 · 2019: 25 · 2018: 41 · 2017: 31 · 2016: 29 · 2015: 43 · 2014: 36 · 2013: 24 · 2012: 34
- FWCI
- 25.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- extrapulmonary tuberculosis, Xpert MTB/RIF, rapid molecular detection, Mycobacterium tuberculosis, sensitivity and specificity, urine samples, fecal samples, pleural fluid, cerebrospinal fluid, gastric aspirate, tissue samples, cultural comparison
- MeSH terms
- Automation, Bacteriological Techniques, Germany, Humans, Mycobacterium tuberculosis, Sensitivity and Specificity, Time Factors, Tuberculosis, Molecular Diagnostic Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System. https://app.cochat.ai/papers/10.1128/jcm.02268-10
- The paper
- Hillemann, D., Rüsch-Gerdes, S., Boehme, C., & Richter, E. (2011). Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.02268-10
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.